Lupin Outlook for the Week (Sep 03, 2018 – Sep 07, 2018)
EquityPandit’s Outlook for Lupin for the week (Sep 03, 2018 – Sep 07, 2018) : LUPIN: Lupin closed the week on positive note gaining around 2.60%....
Tag : Lupin
Lupin Outlook for the Week (Aug 27, 2018 – Aug 31, 2018)
EquityPandit’s Outlook for Lupin for the week (Aug 27, 2018 – Aug 31, 2018) : LUPIN: Lupin closed the week on positive note gaining around 3.00%....
Lupin Outlook for the Week (Aug 20, 2018 – Aug 24, 2018)
EquityPandit’s Outlook for Lupin for the week (Aug 20, 2018 – Aug 24, 2018) : LUPIN: Lupin closed the week on positive note gaining around 8.90%....
Lupin Outlook for the Week (Aug 13, 2018 – Aug 17, 2018)
EquityPandit’s Outlook for Lupin for the week (Aug 13, 2018 – Aug 17, 2018) : LUPIN: Lupin closed the week on negative note losing around 8.60%....
Lupin Profit Plummets 43% During Q1 FY19
Indian pharmaceutical company Lupin posted their first quarterly report for current fiscal year with a net consolidated profit of Rs. 202.33 crore which is a...
Lupin Outlook for the Week (Aug 06, 2018 – Aug 10, 2018)
EquityPandit’s Outlook for Lupin for the week (Aug 06, 2018 – Aug 10, 2018) : LUPIN: Lupin closed the week on positive note gaining around 8.70%....
Lupin Outlook for the Week (July 30, 2018 – Aug 03, 2018)
EquityPandit’s Outlook for Lupin for the week (July 30, 2018 – Aug 03, 2018) : LUPIN: Lupin closed the week on positive note gaining around 1.80%....
Lupin launches Desoximetasone Topical Spray, in US market
Lupin has launched Desoximetasone Topical Spray, in the US market. It is used for treatment of plaque psoriasis. In a regulatory filing the company stated,...
Lupin Outlook for the Week (July 23, 2018 – July 27, 2018)
EquityPandit’s Outlook for Lupin for the week (July 16, 2018 – July 20, 2018) : LUPIN: Lupin closed the week on negative note losing around 7.50%....
Lupin receives approval for its Goa facility, from UK MHRA
Lupin has received approval from the UK health regulator its Goa facility. In a regulatory filing the company stated that, it has received approval from UK MHRA...